1. Home
  2. FISV vs ZTS Comparison

FISV vs ZTS Comparison

Compare FISV & ZTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Fiserv Inc.

FISV

Fiserv Inc.

HOLD

Current Price

$47.59

Market Cap

28.3B

Sector

Real Estate

ML Signal

HOLD

Logo Zoetis Inc.

ZTS

Zoetis Inc.

HOLD

Current Price

$79.68

Market Cap

29.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FISV
ZTS
Founded
1984
1952
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
28.3B
29.0B
IPO Year
1994
2012

Fundamental Metrics

Financial Performance
Metric
FISV
ZTS
Price
$47.59
$79.68
Analyst Decision
Hold
Buy
Analyst Count
36
18
Target Price
$58.15
★ $93.47
AVG Volume (30 Days)
★ 5.7M
2.9M
Earning Date
11-03-2026
11-05-2026
Dividend Yield
N/A
★ 2.67%
EPS Growth
★ 17.84
10.05
EPS
2.24
★ 3.08
Revenue
★ $21,193,000,000.00
$9,467,000,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$3.51
$2.43
P/E Ratio
★ $21.21
$25.72
Revenue Growth
★ 3.60
2.28
52 Week Low
$44.10
$68.92
52 Week High
$70.41
$148.30

Technical Indicators

Market Signals
Indicator
FISV
ZTS
Relative Strength Index (RSI) 50.56 70.01
Support Level $47.04 $72.36
Resistance Level $55.99 $80.17
Average True Range (ATR) 1.04 1.75
MACD 0.44 1.05
Stochastic Oscillator 84.93 91.95

Price Performance

Historical Comparison
FISV
ZTS

About FISV Fiserv Inc.

Fiserv is a leading provider of core processing and complementary services, such as electronic funds transfer, payment processing, and loan processing, for US banks and credit unions, with a focus on small and midsize banks. Following its 2019 merger with First Data, Fiserv also provides payment processing services to merchants. About 10% of the company's revenue is generated internationally.

About ZTS Zoetis Inc.

Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns roughly 35% of total revenue from production animals (cattle, pigs, poultry, and so on) and nearly 65% from companion animal (dogs, horses, cats) products. Its US business is skewed even more heavily toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.

Share on Social Networks: